.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Details for Patent: 5,028,628

« Back to Dashboard

Details for Patent: 5,028,628

Title: Methods of treating pulmonary hypertension
Abstract:The present invention is concerned with methods for the treatment and diagnosis of pulmonary hypertension which comprise the administration of an effective amount of a compound of formula (I) ##STR1## wherein X is hydrogen or methyl; Y is --O-- or --CH.sub.2 --; R is --C(R.sup.1)(R.sup.2)CH.sub.2 CH.sub.2 CH.sub.2 CH.sub.3 wherein R.sup.1 and R.sup.2, which may be the same or different, are selected from hydrogen and halogen; and the dotted line represents an optional double bond; and pharmaceutically acceptable salts and acid derivatives thereof. Medicaments and diagnostic aids for use in the methods of the invention are also within the scope of the invention.
Inventor(s): Tadepalli; Anjaneyulu S. (Durham, NC), Whittle; Brendan J. R. (Beckenham, GB2)
Assignee: Burroughs Wellcome Co. (Research Triangle Park, NC)
Filing Date:Oct 13, 1989
Application Number:07/421,453
Claims:1. A method of treating pulmonary hypertension in a patient who is suffering from pulmonary hypertension comprising administering to said patient an effective pulmonary hypertension treatment amount of the compound (5Z, 9S)-9-methyl-6a-carba-prostaglandin I.sub.2.

2. A method of treating pulmonary hypertension in a patient who is suffering from pulmonary hypertension comprising administering to said patient an effective pulmonary hypertension treatment amount of a pharmaceutically acceptable salt of the compound (5Z, 9S)-9-methyl-6a-carba-prostaglandin I.sub.2.

3. A method of treating pulmonary hypertension in a patient who is suffering from pulmonary hypertension comprising administering to said patient an effective pulmonary hypertension treatment amount of a C.sub.1-4 alkyl ester or amide of the compound (5Z, 9S)-9-methyl-6a-carba-prostaglandin I.sub.2.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc